| Size & multiples | |||
| Market Cap | — | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | — | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | — | Buyback Yield | — |
| Owner Earnings (TTM) | -CNY 9.5M | Owner Earnings Yield | — |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | −1.00 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | −0.98% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −4.13% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF sits 2616% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Flows latest annual · EPS TTM -CNY 0.71 · revenue TTM CNY 460.5M · FCF TTM -CNY 258.1M (in CNY)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| Net Margin | -20.2% | -21.2% | -325.3%–7.2% | 51 ↑strong |
| Operating Margin | -56.8% | -34.5% | -552.0%–8.0% | 45 ↓weak |
